Home›Stock Screener›Dipna Pharmachem›Financial Statements

Dipna Pharmachem Complete Financial Statements

9 Years of Data
2026 - 2018

In FY2026, Dipna Pharmachem (DPL) reported revenue ₹129 Cr, net profit ₹3 Cr and EPS ₹1.00, with a net profit margin of 2.3% and ROE of 4.8%. Full financial statements from FY2018 to FY2026 (9 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Compare with DPL fair price to assess whether the stock is under or overvalued.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 2.33% 2026 data
EBITDA Margin 3.88% 2026 data
Operating Margin 4.00% 2026 data
Return on Assets 1.46% 2026 data
Return on Equity 4.84% 2026 data

Balance Sheet Ratios

Current Ratio 15.40 2026 data
Equity Ratio 30.10% 2026 data
Asset Turnover 0.63 2026 data

DPL Revenue, Net Profit & EBITDA — Year-on-Year Growth

DPL YoY (March 2025 vs March 2026) — revenue +3.2%, net profit +200.0%, EBITDA +66.7%, expenses +1.6%.

Revenue Growth
+3.2%
Year-over-Year
Net Profit Growth
+200.0%
Year-over-Year
EBITDA Growth
+66.7%
Year-over-Year
Expense Growth
+1.6%
Year-over-Year
Assets Growth
+56.1%
Year-over-Year
Equity Growth
+59.0%
Year-over-Year
Operating Cash Flow Growth
-80.0%
Year-over-Year
Financing Cash Flow Growth
-128.6%
Year-over-Year

DPL Income Statement — Revenue, EBITDA & Net Profit

Dipna Pharmachem revenue ₹129 Cr, EBITDA ₹5 Cr, net profit ₹3 Cr, EPS ₹1.00 (2026) — net profit margin 2.3%. For live price, earnings ratios and company overview, see DPL share price.

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018
Revenue 129 125 164 100 73 31 31 20 17
Expenses 124 122 161 98 71 31 31 20 17
EBITDA 5 3 3 2 2 0 0 0 0
Operating Profit Margin % 4.00% 3.00% 2.00% 2.00% 3.00% 1.00% 0.00% 0.00% 0.00%
Depreciation 0 0 0 0 0 0 0 0 0
Interest 1 2 2 1 1 0 0 0 0
Profit Before Tax 4 1 1 1 2 0 0 0 0
Tax 1 0 0 1 0 0 0 0 0
Net Profit 3 1 1 1 1 0 0 0 0
Earnings Per Share (₹) 1.00 0.41 0.45 0.76 333.39 6.91 16.86 9.15 17.27

DPL Balance Sheet — Assets, Liabilities & Shareholders' Equity

DPL total assets ₹206 Cr, total equity ₹62 Cr, total liabilities ₹ Cr (2026) — ROE 4.8%.

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018
ASSETS
Total Assets 206 132 133 78 36 25 18 14 11
Current Assets 154 132 133 78 36 25 18 14 11
Fixed Assets 0 0 0 0 0 0 0 0 0
Capital Work in Progress 0 0 0 0 0 0 0 0 0
Investments 42 0 0 0 0 0 0 0 0
Other Assets 0 132 133 78 36 25 18 14 11
LIABILITIES
Total Liabilities
Current Liabilities 10 9 13 11 6 4 0 0 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 62 39 38 24 2 1 1 1 1
Share Capital 26 24 24 12 0 0 0 0 0
Reserves & Surplus 36 14 14 12 2 1 1 1 0

DPL Cash Flow Statement — Operating, Investing & Financing

Dipna Pharmachem operating cash flow ₹-9 Cr, investing ₹0 Cr, financing ₹-4 Cr, net cash flow ₹-13 Cr (2025).

Periods ₹ Crores
Particulars March 2025 March 2024 March 2023 March 2022 March 2021 March 2020
Operating Activities -9 -5 -21 3 -2 -3
Investing Activities 0 0 0 0 0 0
Financing Activities -4 14 27 -3 3 3
Net Cash Flow -13 8 6 0 0 0